Financials

  • Market Capitalization 5.57 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.05
Rapporto prezzo/fatturato
39.53

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4944
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.66 USD-6.01%-8.59%-14.74%+638.89%5.70 M USD
4948
PULM
Pulmatrix, Inc. - Common Stock
1.61 USD-3.59%-6.94%+15.00%-74.96%5.88 M USD
4960
APVO
Aptevo Therapeutics Inc. - Common Stock
4.60 USD+10.84%+2.00%-3.77%-31.85%5.73 M USD
4962
NCNA
NuCana plc - American Depositary Shares
1.32 USD+3.13%-5.04%-34.33%-38.60%5.49 M USD

Notizie